Nisa Investment Advisors
SNDX icon

Nisa Investment Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History

Nisa Investment Advisors’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1K Sell
600
-533
-47% -$11.1K ﹤0.01% 2395
2026
Q1 		$26.5K Buy
1,133
+21
+2% +$456 ﹤0.01% 1910
2025
Q4 		$23.4K Hold
1,112
– – ﹤0.01% 1880
2025
Q3 		$17.1K Buy
1,112
+11
+1% +$144 ﹤0.01% 2063
2025
Q2 		$10.3K Buy
1,101
+222
+25% +$2.44K ﹤0.01% 2248
2025
Q1 		$10.8K Buy
879
+61
+7% +$860 ﹤0.01% 2079
2024
Q4 		$10.8K Sell
818
-243
-23% -$4.16K ﹤0.01% 2115
2024
Q3 		$20.4K Buy
1,061
+49
+5% +$1.01K ﹤0.01% 1900
2024
Q2 		$20.8K Buy
1,012
+908
+873% +$19K ﹤0.01% 1922
2024
Q1 		$2.48K Buy
104
+69
+197% +$1.54K ﹤0.01% 2200
2023
Q4 		$756 Sell
35
-29
-45% -$446 ﹤0.01% 2323
2023
Q3 		$929 Sell
64
-1,368
-96% -$25.9K ﹤0.01% 2406
2023
Q2 		$30K Buy
1,432
+580
+68% +$12.1K ﹤0.01% 1940
2023
Q1 		$18K Buy
852
+810
+1,929% +$20.1K ﹤0.01% 2043
2022
Q4 		$1K Hold
42
– – ﹤0.01% 2501
2022
Q3 		$1K Buy
+42
New +$942 ﹤0.01% 2504
2022
Q2 		– Sell
-2,160
Closed -$38K – 2498
2022
Q1 		$38K Hold
2,160
– – ﹤0.01% 1914
2021
Q4 		$35K Sell
2,160
-240
-10% -$4.43K ﹤0.01% 1813
2021
Q3 		$46K Hold
2,400
– – ﹤0.01% 1956
2021
Q2 		$41K Buy
2,400
+1,900
+380% +$34.8K ﹤0.01% 1989
2021
Q1 		$11K Hold
500
– – ﹤0.01% 2200
2020
Q4 		$11K Buy
+500
New +$10.4K ﹤0.01% 2203

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Nisa Investment Advisors's SNDX Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Syndax Pharmaceuticals (SNDX) stake by 47% in Q2 2026, selling an estimated $11.1K and leaving 600 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2395.

Nisa Investment Advisors first reported a position in SNDX in Q4 2020 and has held it in 22 quarters since. The position peaked at $46K in Q3 2021. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Nisa Investment Advisors held 600 shares of Syndax Pharmaceuticals worth $13.1K as of Q2 2026.
  • Nisa Investment Advisors sold 533 Syndax Pharmaceuticals shares in Q2 2026, an estimated $11.1K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2395 holding.
  • Nisa Investment Advisors first reported a position in Syndax Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • Nisa Investment Advisors's Syndax Pharmaceuticals position peaked at $46K in Q3 2021.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.